Match each clinical presentation of a suspected gynecologic infection to the most appropriate initial pharmacologic management based on current guidelines.
- A 21-year-old non-pregnant woman presents with mild lower abdominal pain and cervical motion tenderness. She is afebrile and tolerating oral intake.Single-dose intramuscular ceftriaxone combined with a 14-day course of oral doxycycline and oral metronidazole
- A 26-year-old woman presents with severe pelvic pain, intractable vomiting, and a temperature of (). Ultrasound reveals a 6-centimeter complex adnexal mass.Hospital admission for intravenous cefoxitin and intravenous doxycycline
- A 30-year-old woman at 14 weeks gestation complains of a malodorous, thin, grayish-white vaginal discharge. Vaginal pH is 5.5 and an amine odor is present on KOH prep.Oral metronidazole monotherapy for 7 days
- A 23-year-old asymptomatic woman tests positive for *Chlamydia trachomatis* and negative for *Neisseria gonorrhoeae* on routine nucleic acid amplification testing.Oral doxycycline monotherapy for 7 days
Cevap
Uncomplicated PID is treated with IM ceftriaxone plus oral doxycycline and metronidazole. Tubo-ovarian abscesses require inpatient IV cefoxitin and doxycycline. Bacterial vaginosis in pregnancy is treated with oral metronidazole. Isolated chlamydial infection is treated with a 7-day course of oral doxycycline.
Each clinical presentation necessitates a targeted approach based on current CDC guidelines. Uncomplicated PID requires outpatient coverage for gonorrhea, chlamydia, and anaerobes (ceftriaxone + doxycycline + metronidazole). Complicated PID, such as a tubo-ovarian abscess, necessitates hospital admission and IV antibiotics (cefoxitin + doxycycline). Bacterial vaginosis is safely treated with metronidazole during pregnancy. Finally, uncomplicated chlamydia is best treated with a 7-day course of oral doxycycline.
Adım Adım Çözüm
Anahtar Kavram
Pharmacologic management of gynecologic infections is determined by the specific pathogen, disease severity (e.g., uncomplicated PID vs. TOA), and specific patient factors (e.g., pregnancy).